NMS·Healthcare·$491M·#283 / 520 in Healthcare
VALN Valneva SE
40HIGH RISK
CATEGORY BREAKDOWN
GROWTH5
QUALITY32
STABILITY57
VALUATION89
GOVERNANCE33
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+3.0%
5
> 50% strong
Gross Margin
Revenue retained after direct costs
38.7%
53
> 50% strong
Cash Runway
Months of cash at current burn rate
25 months
86
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
195.2%
0
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.1x
89
< 3x strong
Rule of 40
Growth rate plus operating margin
-44
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
0.0%
0
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-44.3%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE VALN WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when VALN's score changes by 5+ points.
DATA INFO
Last updated: Jul 1, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.